duloxetine HCl
ApprovedCompleted 0 views this week 0 watching⚡ Active
Interest: 43/100
43
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Stress Urinary Incontinence
Conditions
Stress Urinary Incontinence
Trial Timeline
Feb 1, 2004 → Jul 1, 2005
NCT ID
NCT00190905About duloxetine HCl
duloxetine HCl is a approved stage product being developed by Eli Lilly for Stress Urinary Incontinence. The current trial status is completed. This product is registered under clinical trial identifier NCT00190905. Target conditions include Stress Urinary Incontinence.
What happened to similar drugs?
5 of 20 similar drugs in Stress Urinary Incontinence were approved
Approved (5) Terminated (1) Active (15)
Hype Score Breakdown
Clinical
20
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00190905 | Approved | Completed |
Competing Products
20 competing products in Stress Urinary Incontinence
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Duloxetine + placebo | Eli Lilly | Phase 2 | 35 |
| agenT-797 | MiNK Therapeutics | Phase 1 | 19 |
| Thermal stress and performance without a pre-cooling protocol | Petros Pharmaceuticals | Pre-clinical | 16 |
| solifenacin | Astellas Pharma | Approved | 43 |
| Sivelestat | Eli Lilly | Phase 1/2 | 32 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 40 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 40 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Duloxetine hydrochloride | Eli Lilly | Phase 3 | 36 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| duloxetine + Placebo | Eli Lilly | Phase 2 | 35 |
| Exenatide + Insulin | Eli Lilly | Phase 2/3 | 38 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Orforglipron + Placebo | Eli Lilly | Phase 3 | 47 |
| Duloxetine hydrochloride + placebo | Eli Lilly | Approved | 43 |
| Duloxetine + Placebo | Eli Lilly | Phase 3 | 40 |
| duloxetine + placebo | Eli Lilly | Phase 3 | 40 |
| Duloxetine | Eli Lilly | Phase 3 | 40 |
| Duloxetine Hydrochloride + placebo | Eli Lilly | Phase 3 | 40 |